Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2025 Earnings Call Transcript February 24, 2026
Harmony Biosciences Holdings, Inc. misses on earnings expectations. Reported EPS is $0.38 EPS, expectations were $0.84.
Operator: Good morning. My name is Angela, and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony Biosciences’ Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that...
